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Optimal Control Approach For HIV-1 Infection in
CD4+T Cells with RTI and PI Treatments
R. Heru Tjahjana and Sutimin
Abstract—The purpose of this paper is to expose the optimal
approach of controlling HIV-1 infection in CD4+T cells with
Reverse Transcriptease Inhibitors (RTI) and Protease Inhibitors
(PI) treatments. The scope of the paper includes a proposed
model of the dynamic system of HIV-1 infection in CD4 cells
with RTI and PI as controls and a proposed objective function
model that minimizes infected CD4+T Cells, the population of
free virus and therapeutic costs. From the dynamics system
model and objective function model, we designed an optimal
control for HIV-1 infection control. In this paper, we obtained
optimal control for RTI and PI therapies. The results of this
paper are as follows: by using the optimal control approach,
we obtained infectious control strategy that minimizes actively
infected CD4+T Cells, the population of free virus and the cost
of treatment. In other words, optimal control is a good approach
in determining infection control strategies that minimizes the
objective function.
Index Terms—CD4+T Cells, RTI, PI, HIV-1 Infection.
I. INTRODUCTION
ACQUIRED Immunodeficiency Syndrome (AIDS) iscaused by HIV infection, one of the dangerous diseases
that leads to death. In Indonesia, based on the report from the
Ministry of Health, until March 31st, 2016, there are more than
13,200 people died from AIDS, 198.219 people are infected by
HIV and 78,292 people are infected by AIDS. From the data,
53% of the infection are transmitted among heterosexuals and
it is the highest group getting HIV infection. Many researchers
are interested in studying HIV infection.
The study about HIV infection was conducted by Srivastava
et al. They considered incomplete Reverse Transcription (RT)
of HIV life cycle in CD4+ T cells and the effect of RTI drug
to block the infection of CD4+ T cells [1]. Elaiw developed
a model to capture HIV infection regarding the interaction of
virus with both CD4+ T cells and macrophage and studied the
behavior of global stability of equilibriums for the dynamical
model due to the effect of antiretroviral treatment [2]. Tarfulea
proposed a mathematical model taking into account the effect
of combined RTI and PI drug classes to capture the dynamical
behavior of HIV infection. It shows that the adherence level
in taking drug determine the progress of HIV infection.
The combination of RTI and PI treatments become a better
treatment than that of monotherapy of RTI or PI, and drug
resistance increases viral load in the body [3]. Perelson and
Ribeiro used a simple model to reveal the quantitative findings
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of HIV biology for acute HIV infection, drug response and
the emergence of viral variants [4]. Chirove et al. developed
a host model to capture the spread of HIV-1 infection that
is transmitted from free virus interaction to target cells and
contact of infected cells to healthy cells. Chirove et al. also
took into account Langerhans target cells in the mathematical
model. The infection among target cells take place due to the
interaction between virus and target cells, and the interaction
between infected cells and susceptible target cells. The results
show that the progress of HIV infection is determined by the
critical values of virus production by infected CD4+ T cells.
Other results show that the infection cycles in the infection
process are obtained [5]. Meanwhile, Sutimin et al. developed
a model taking into account the combination effect of RTI
and PI drugs to block the HIV-1 infection. The drug response
of target cells depends on the characteristic of immune cells,
thereby the immune system of each individual shows different
drug response. In the model, they divided Langerhans and
CD4+ T cells into sub classes namely: sub class containing the
active drugs and subclass which is not acquiring drugs [6], [7].
Sutimin et al. developed and analyzed a mathematical model
incorporating the infection process through cell to cell contact
of CD4+T cells, CTL compartment and the combination of
RTI and PI treatments [8].
II. THE PROPOSED MODEL
In this section, the proposed mathematical model is ex-
plained in detail. The mathematical model is developed from
[1], [6], [7]. In [1], Sivastava et al. did not incorporating cell-
cell viral transmission. In [6], [7], although considering cell-
cell transmission but in the studies did not taken into account
incomplete reverse transcription in latent infection of CD4+ T
cells. In the proposed model, we incorporate viral transmission
both through cell-to-cell and the effect of incomplete reverse
transcription in latent infection of CD4+T cells. The mathe-
matical model introduced the interaction between the infected
CD4+ T cells and healthy CD4+ T cells, virus clearance
by CD4+ T cells, and the effect of PI drug in blocking
the viral replication in infected CD4+ T cells. The complete
model consists of two models. The first model is a dynamical
model and the second one is a model of objective function.
The dynamical model describes the spread of HIV-1 infection
within host cells and the objective functional model describes
minimization of infected CD4+T Cells, the population of free
virus and the cost of therapy.
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The proposed dynamical model can be presented as follows
dT
dt
= λ −µt −β1 V T −β2V T +(εRT Iα +ρ)T1,
dT1
dt
= β1V T +β2V T − (µ1 +α +ρ)T1,
dTi
dt
= (1− εRT I)αT 1 − (µt +δ )Ti,
dV
dt
= Nδ (1− εPI)Ti−µvV −φV T.
(1)





(C1Ti +C2V +w1ε2RT I +w2ε
2
PI) dt. (2)
Consider (1), the populations of susceptible CD4+ T cells
symbolized by T die with the constant rate µt . The recruitment
rate of CD4+ T cells can be denoted by λ . The population is
infected by free virus and CD4+ T cells with the constant
rate β1 and β2, respectively. Sometimes, viruses enter into
CD4+ T cell and Reverse Transcription (RT) takes place in
cytoplasm. The symbol T1 is incomplete RT CD4+ T cells
and may return to susceptible with the constant rate ρ . Once
the cells acquire active RTI drug, it returns to healthy with
the rate α due to the effectiveness of drug. The population
diminishes due to the natural death with the constant rate
µt . The symbol Ti represents CD4+ T cells that take place
complete RT, thereby it is called the actively infected CD4+
T cells. These population diminish due to the natural death and
lysis at the constant rate µt , δ , respectively, and the infection
rate of the population in class T1 reduces to (1− εRT I)α due to
the effectiveness of RTI drug. The population of free virus V is
produced by the infected CD4+ T cells with the average of the
virus number decreases to (1− εPI)Nδ due to the effect of PI
treatment, and diminishes due to natural death and clearance
at the constant rates µv and φ , respectively. The constant N
and µt are the average number of virions produced by infected
CD4+ T cells and the constant natural death rate of CD4+ T
cells, respectively. In control theory, model (1) consists of 4
state variables and two control variables. The state variables
are T , T1, Ti and V . The control variables are εRT I and εPI .
The values of the parameters used in this paper can be seen
in Table I.
The parameter values used in this paper are based on
estimation and data of HIV sufferers from the laboratory
as reported in the paper referenced. For parameter values
according to the reference values are in an interval, estimated
by taking one value in the interval. Another reason why this
paper takes parameter values such as those used in the next
simulations is because recent papers on HIV-1 [6], [7], [8]
also refer to those values. With the explanation regarding the
development of the model at the beginning of Section II and
the reasons for taking the values of the parameters above, it
can be said that the proposed model is a valid model.
III. MATHEMATICAL ANALYSIS
In this section, controllability analysis and the existence of
optimal control is reported. In control theory, dynamical model
TABLE I: Values of the Parameters
Parameters Values Descriptions Units Source(s)
λ 10 or 20 Production rate




















α 0.26 Transmission rate
of T1 due to in-
complete the RT
l/day [1]
µt 0.01 Natural death
rate of CD4+ T
cells
l/day [14]
µv 2.40 Natural death
rate of free virus
l/day [15]
µ1 0.015 Natural death
rate of CD4+
T cells due to
inflammation
l/day [16]















(1) is nonlinear control system. The controllability analysis of
the model (1) presented in the Theorem 1 as follows.
Theorem 1: The dynamical model (1) is locally accessible
Proof: The proof starts from change the form of model
(1) to Affine system. In Affine system form, model (1) has a
drift. The next step is generate controllability matrix through
Lie Bracket. After check the rank of controllability matrix and
the result is full rank, so we can conclude that the model (1)
is locally accessible.
After controllability analysis, the next analysis is existence
of optimal control. The existence of optimal control can be
exposed in Theorem 2 as follows.
Theorem 2: Optimal control problem with dynamical model
(1) and objective function (2) exist.
Proof: The proof is based on the convexity of each
summand in objective function (2). Since each summand is
convex and summation of convex function is also convex then
the objective functional (2) is convex. If the objective function
(2) is convex then the solution of optimal control problem
exists.
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Fig. 1: Values of objective function.
IV. SIMULATION RESULTS
Besides values of the parameters, another important thing in
the simulation is determination of initial condition T (0), T1(0),
Ti(0) and V (0). The process of control design for simulation,
starts from dynamical model (1). The values of the parameters
from Table I are subtituted in (1) and (2), so we have a system
of differential equations. With the system of differential equa-
tions and objective functional (2), the Hamiltonian function is
obtained. After Hamiltonian function, the Hamiltonian system
is obtained. Next, the Pontryagin Maximum Principle is used
to compute the optimal condition for each control variables.
Therefore, the equation for each control variable is obtained.
Then, each control variable is subtituted to the Hamitonian
system and we have the ordinary differential equation system
with control variable which has been substituted. The simula-
tion result is obtained from this ordinary differential equation
system with initial values for T (0), T1(0), Ti(0) and V (0) are
850, 0, 41 and 3.76, respectively. The initial and final times,
namely 0 and 70, respectively.
In this paper, the numerical method used to solve the
ordinary differential equation system numerically is Runga-
Kutta method. The computation is performed using the Matlab
software. The Matlab version used to make simulations is
Matlab R 2008a.
The main result of simulation can be described in Fig. 1
and Fig. 2 as follows. The values of objective function J and
control variables u1 and u2 are plotted in Fig. 1 and Fig. 2,
respectively.
Considering objective function (2), as described in Section
II, the objective of this paper is to minimize the objective cost.
Trend of objective function value is decreasing as can be seen
in Fig. 1. The plot of simulation to minimize the objective
function shows this trend. Plot of objective function in Fig.
1 indicates that efforts to minimize objective functions have
been seen, although the functional plot of J is seen to increase
at a time interval of about 350 to 450 increased compared to
the value of the function at the previous interval of 150 until
345. This is possible because there are values in functional
costs whose value rises at the time in that interval. Next, after
450, it can be seen that the trend of the value of J looks to
continue to decreased.
Fig. 2: Plot of controls versus time.
Subsequent simulations are u1 and u2. As the objective of
this paper, it is to find the optimal strategy through optimum
control for 70 days, for each of the minimum u1 and u2,
the simulation result is shown in Fig. 2. It is noted that
the objective function (2), besides minimizing J, the main
objective of this paper is to determine how the minimum
possible u1 and u2 can minimize the objective function value.
Since u1 represents the cost of RTI and u2 represents the cost
of PI, and it is only natural that these costs are the matters that
must be minimized. Plot of u1 and u2 versus time can seen in
Fig. 2.
V. CONCLUSIONS
With the optimal control approach, optimal control for
RTI and PI treatments can be found that they simultaneously
minimize functional objectives. The mathematical model for
the spread of HIV-1 infection is within the host cells of four
nonlinear differential equations. From the dynamics model (1)
and objective function (2), with the optimal control approach,
it can be obtain the simulation results of minimizing objective
functional value and simulation of control determination for
the minimum RTI and PI. The results are reproduced in plots
u1 and u2 throughout the initial and final times, namely 0 and
70. For the record, different parameter values can provide plot
results that may not be the same as the simulation plot results.
However, the values of parameters taken from these references
in the source make a convincing result for the reader. From
Fig. 1, it can be seen that the value of objective function can
be minimized. From Fig. 2, the minimization u1 and u2 was
successfully shown.
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